Prosecution Insights
Last updated: April 19, 2026

Health Research Inc.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
3
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18253384 COMPOUNDS AND METHODS TO TARGET GLUCOSE-STIMULATED PHOSPHOHISTIDINE SIGNALING AND ESOPHAGEAL CANCER GROWTH RZECZYCKI, PHILLIP MATTHEW 1625 Non-Final OA May 17, 2023
18252024 METHODS FOR DISRUPTING MITOCHONDRIAL UNFOLDED PROTEIN RESPONSE HEASLEY, MEGHAN CHRISTINE 1626 Non-Final OA May 05, 2023
18040670 METHODS AND SYSTEMS FOR OPTIMIZING VOLUMETRIC MODULATED ARC THERAPY (VMAT) TREATMENT PLANS TOOHEY, RICHARD ORLANDO 2884 Non-Final OA Feb 06, 2023
18001001 JOINTED DEVICE FOR AUTOMATIC SUTURE AND METHOD FOR SAME RESTAINO, ANDREW PETER 3771 Final Rejection Dec 07, 2022
17638518 REACTIVATING P53 MUTANTS FOR CANCER TREATMENT BY TARGETING PROLIDASE (PEPD) HUDSON, AMY ROSE 1636 Final Rejection Feb 25, 2022
17289519 COMBINATION TREATMENT WITH ANTI-CD123 ANTIBODY DRUG CONJUGATE AND PARP INHIBITOR KOLKER, DANIEL E 1645 Non-Final OA Apr 28, 2021
16979464 INDUCTION SPACER FOR INHALER MOON, MATTHEW RYAN 3785 Final Rejection Sep 09, 2020

Managing Health Research Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month